Page 400 - Academic Press Encyclopedia of Physical Science and Technology 3rd Chemical Engineering
P. 400

P1: GLQ Final Pages
 Encyclopedia of Physical Science and Technology  EN009K-419  July 19, 2001  20:57







              Membranes, Synthetic, Applications                                                          335

              attachment to the membrane matrix, or simply confined  asymmetric synthesis, which directly yields the desired
              in solution form in the pores of a membrane and bound  single isomer. Some work on racemic resolution contin-
              externally by immiscible phases. Substrate reaching the  ues today with an emphasis on the production of specialty
              enzyme by convection or diffusion is converted to prod-  chemicals.
              uct. Alternatively, the enzyme and the substrate solution  Other  applications  of  membrane  bioreactors  proved
              may be placed on opposite sides of the membrane so that  more sustainable. The first utilizes membranes as an ad-
              the reaction may occur at the membrane interface. In ei-  junct to conventional bioreactors rather than their replace-
              ther case, the fermentation vessel is eliminated, as is the  ment. For example, as bioprocesses are scaled up to meet
              need to process large volumes of dilute broth at the end  increasing demands of genetically engineered products,
              of the reaction. Hollow fibers are the preferred geome-  every  component  in  a  bioreactor  needs  to  be  operated
              try for membrane reactors because the biocatalysts can  as efficiently as possible. For mammalian cell cultures,
              be confined on the shell side, lumen side, or within the  high cell densities can be reached by replacing traditional
              macroporous fiber walls, and because circulation on both  methods of gas exchange (e.g., direct sparging, surface or
              sides of hollow fibers is convenient.              head-space aeration) with gas exchange membranes made
                Attempts at using membrane bioreactors at the process  from silicone rubber or microporous polytetrafluoroethy-
              scale have been successful to different extents. One early  lene, both of which operate under bubble-free conditions
              example of a commercial-scale operation was the enzy-  that are much less disruptive to the cell culture. In a similar
              matic resolution of optical isomers to produce pharma-  approach, a “dialysis fermentation” system is assembled
              ceutical intermediates developed in the mid-1980s. By in-  by immersing tubular dialysis membrane in a conventional
              corporating a stereoselective enzyme in the microporous  stirred-tank fermenter (“Improved tools,” 2000). Nutrient
              structure of a membrane, then supplying the racemic sub-  solution containing glucose and amino acids, for exam-
              strate on one side of the membrane, one of the isomers  ple, is circulated through the dialysis tubing to supply the
              is  converted  by  the  enzyme  and  diffuses  to  the  oppo-  cells in the fermenter; the same stream carries away spent
              site  side  of  the  membrane  where  it  can  be  recovered.  media containing lactates and ammonia. In this way, cell
              The membrane serves several functions simultaneously, as  densities several times higher than those in a conventional
              shown in Fig. 46: containing the enzyme, offering a stable  fermenter may be reached, resulting in correspondingly
              interface for contacting the aqueous and organic phases,  higher product yield. Another benefit is that essentially no
              and removing inhibitory products continuously during the  fermentation product is lost to the nutrient/waste stream
              reaction. This elegant process was briefly commercialized  because dialysis membranes are only permeable to low-
              to  resolve  an  intermediate  to  the  antihypertensive  drug  molecular-weight compounds but not to the biomolecules
              diltiazem (Lopez and Matson, 1997). However, the biore-  of interest. In a third example, monoclonal antibodies are
              actor approach was rendered obsolete with the advent of  produced by culturing hybridoma cells in a bioreactor
                                                                chamber equipped with two membrane systems: a first
                                                                hollow fiber system circulating nutrient solutions and a
                                                                second, flat-sheet membrane forming the gas exchange
                                                                interface to supply oxygen to the cells, as shown in Fig. 47.
                                                                  Another noteworthy application area for membrane
                                                                bioreactors is in wastewater or industrial effluent treat-
                                                                ment. Since the early to middle 1990s, there has been a
                                                                resurgence of interest in deploying membrane systems for
                                                                waste remediation, including oily metal finishing wastes.
                                                                A combination of increasingly stringent environmental
                                                                protection regulations, the energy-efficient character of
                                                                membrane processes, and the ease with which membrane
                                                                systems may be adapted to different scale operations,
                                                                have made it attractive to design and operate customized
                                                                microbial/enzymatic digestion systems using membranes
                                                                to contain and compartmentalize the biochemical reac-
                                                                tion.  (Stephenson,  Brindle,  Judd,  and  Jefferson,  2000).
                                                                Much current effort is focused on managing fouling
                                                                and sustaining reactor productivity. These applications
              FIGURE 46  Membrane bioreactor in a multiphasic configuration  further illustrate a gradual transition in this field.
              with reversible enzyme containment.               Where membrane bioreactors were once used almost
   395   396   397   398   399   400   401   402   403   404   405